Navigation Links
Hard To Treat Diseases (HTDS) Slavica BioChem Update on Research Activities
Date:4/22/2009

BELGRADE, April 22 /PRNewswire-FirstCall/ - Hard To Treat Diseases (HTDS) www.htdsmedical.com - HTDS chief scientist Dr. Sanja Pekovic provided updates from a recent medical convention held in Antwerpen; Joint Meeting 2009 Anatomische Gesellschaft - Nederlandse Anatomen Vereniging, Antwerpen, 27-30 March 2009.

Dr. Pekovic reported on the results of recent positive testing being conducted related to the CNS disorder multiple sclerosis and in suppression of reactive astrogliosis after brain injury. This led to a number of preliminary talks for future collaboration with other scientists working in the field. A more detailed review of the research results will be posted separately on the Pink Sheets as a supplementary filing shortly. Notably, this work was supported by the European Cooperation in the Field of Scientific and Technical Research (COST) organization.

Dr. Pekovic also reported the scientific team has started some in vitro studies of purine nucleoside analogues (ribavirin, tiazofurin, the drugs we are investigating) effects on microglial cell culture (there is no current data in the literature about their effect on microglia) in collaboration with professor Thomas Herdegen from Kiel University, Germany, who is also a member of COST as a representative of Germany. Over the last 3 months in the lab, our technicians have learned how to establish microglial cell culture, a valuable next step in the continued research.

HTDS will be providing additional funding to further this work, at the IBISS INSTITUT ZA BIOLOSKA ISTRAZIVANJA SINISA STANKOVIC for Project 143005 headed by professor Mirjana Stojiljkovic.

Safe Harbor Statement

Information in this news release may contain statements about future expectations, plans, prospects or performance of Hard To Treat Diseases Inc that constitute forward-looking statements for purposes of the safe harbor Prov
'/>"/>

SOURCE Hard to Treat Diseases
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. New treatment shows promise against recurrent gynecologic cancers
2. Leading Critical Care Doctor Shifts From Treatment to Empowerment by Helping Americans Create Optimal Health in Their Lives
3. First Patients in United States Receive Innovative Device to Treat Moderate Heart Failure
4. Surveyed Specialists Foresee Greater Use of Parenteral Outpatient Therapy for the Treatment of Osteomyelitis
5. Canadian Medical Device Set to Speed Treatment and Cut Health Care Costs for Common Cause of Vertigo
6. Mayo Clinic researchers formulate treatment combination lethal to pancreatic cancer cells
7. Yashoda Cancer Institute Treats First Patient in India Using RapidArc Radiotherapy Technology
8. For Reducing Mortality, Current and Emerging Therapies Have No Advantage Over Carvedilol in the Treatment of Coronary Heart Disease (Stable Angina)
9. Targeted Treatments Show Mettle Against Advanced Cancers
10. North Carolina Give Kids A Smile! Project Treats Close to 20,000 Children
11. Treatment Algorithm Helps Successfully Manage Diabetes after Transplant Surgery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... Decene is an alkene with the formula ... atoms with one double bond. 1-Decene enters all ... be used as a co-monomer in certain copolymers ... oxo alcohols, synthetic lubricants, synthetic fatty acids, and ... 10% customization on this report. , http://www.micromarketmonitor.com/contact/2523613387-request_for_customization.html ...
(Date:7/30/2014)... 2014 The Europe Phytochemicals & plant ... plant extracts market in Europe with analysis and forecast ... Europe is estimated to grow from around 710.18$ million ... CAGR of 8.4%, for the given period. , Browse ... extracts market report, to get an idea of the ...
(Date:7/30/2014)... diagnosed with depression as preschoolers are likely to suffer ... research shows. , Depressed preschoolers were 2.5 times more ... middle school than kids who were not depressed at ... School of Medicine in St. Louis. , Their study ... American Journal of Psychiatry . , "It,s the same ...
(Date:7/30/2014)... Bringing Disney Excellence to Central Iowa ... the Central Iowa Chapter of the Association for Talent ... renowned professional development course, “Disney’s Approach to Business Excellence,” ... world class workshop will inspire area professionals from businesses ... and satisfy customers. , “Disney 'magic' as I call ...
(Date:7/30/2014)... organs for transplants sounds like something out of a ... day make actual kidneys, livers, hearts and other organs ... journal Langmuir , scientists are reporting new understanding ... a step closer to realizing their goal of making ... and colleagues note that this idea of producing tissues ...
Breaking Medicine News(10 mins):Health News:Europe 1-decene Market is Expected to Reach 251.7 thousand MT in 2018 - New Report by MicroMarket Monitor 2Health News:Europe 1-decene Market is Expected to Reach 251.7 thousand MT in 2018 - New Report by MicroMarket Monitor 3Health News:Europe 1-decene Market is Expected to Reach 251.7 thousand MT in 2018 - New Report by MicroMarket Monitor 4Health News:Europe Phytochemicals & Plant Extracts (Nutraceuticals) Market is Expected to Reach $1,150.64 Million in 2018 - New Report by MicroMarket Monitor 2Health News:Europe Phytochemicals & Plant Extracts (Nutraceuticals) Market is Expected to Reach $1,150.64 Million in 2018 - New Report by MicroMarket Monitor 3Health News:Europe Phytochemicals & Plant Extracts (Nutraceuticals) Market is Expected to Reach $1,150.64 Million in 2018 - New Report by MicroMarket Monitor 4Health News:Europe Phytochemicals & Plant Extracts (Nutraceuticals) Market is Expected to Reach $1,150.64 Million in 2018 - New Report by MicroMarket Monitor 5Health News:Many depressed preschoolers still suffer in later school years 2Health News:Many depressed preschoolers still suffer in later school years 3Health News:Central Iowa Chapter of ATD Hosts Exclusive Disney Institute for Central Iowa Businesses 2Health News:Central Iowa Chapter of ATD Hosts Exclusive Disney Institute for Central Iowa Businesses 3
... study finds , THURSDAY, Dec. 6 (HealthDay News) -- ... she receives surgery after a breast cancer diagnosis, U.S. ... Medical Institutions in Baltimore also found that a lengthy ... , Factors such as socioeconomic status and the cumulative ...
... 6 SGX Pharmaceuticals, Inc.,(Nasdaq: SGXP ) announced today ... treatment of chronic myelogenous leukemia,(CML) at the upcoming American Society ... held December 8th - 11th, 2007 in,Atlanta, Georgia., , ... listed below:, Date: ...
... 6 Arete Therapeutics Inc., a,privately-held biopharmaceutical company ... cardiovascular, inflammatory and,metabolic diseases, today announced the appointment ... "We are very pleased to welcome Don ... operational insights will be of great benefit to ...
... New Product Name Also Unveiled in Ongoing ... Dec. 6 Favrille, Inc. (Nasdaq:,FVRL), a ... treatment of cancer, announced that new data,including ... 2 clinical,trial of Specifid(TM) (formerly FavId(R)), will ...
... US Oncology, the nation,s leading,oncology services company, today ... president and chief operating officer. The appointment,becomes effective ... operating experience, combined with his work in,large diversified ... Bruce Broussard, president of US Oncology.,"His proven success ...
... Wagoner on new data showing first increase in U.S.,teen ... that the,dramatic decrease in teen pregnancy rates in the ... a screeching halt. This unwelcome,development should not come as ... success over the last decade -- the decline in ...
Cached Medicine News:Health News:Black Women Wait Longer for Breast Cancer Surgery 2Health News:SGX Pharmaceuticals BCR-ABL Program to be Presented at the American Society of Hematology 49th Annual Meeting and Exposition 2Health News:SGX Pharmaceuticals BCR-ABL Program to be Presented at the American Society of Hematology 49th Annual Meeting and Exposition 3Health News:SGX Pharmaceuticals BCR-ABL Program to be Presented at the American Society of Hematology 49th Annual Meeting and Exposition 4Health News:Arete Therapeutics Appoints Donald Santel to Board of Directors 2Health News:Favrille to Report New Data on FavId (Now Specifid) at American Society of Hematology Annual Meeting 2Health News:Favrille to Report New Data on FavId (Now Specifid) at American Society of Hematology Annual Meeting 3Health News:Favrille to Report New Data on FavId (Now Specifid) at American Society of Hematology Annual Meeting 4Health News:Favrille to Report New Data on FavId (Now Specifid) at American Society of Hematology Annual Meeting 5Health News:US Oncology Appoints Glen Laschober EVP & Chief Operating Officer 2
(Date:7/30/2014)... and NEW YORK , July 30, ... developer of new products for oncology supportive care, announced ... , has been featured in an article on OncLive.com ... in Head and Neck Cancers."  Dr. Steve Sonis ... on the growing demand seen in the oncology community ...
(Date:7/30/2014)... 2014 /PRNewswire-iReach/ -- This is a professional and ... sodium (CAS 9041-08-1) & calcium (CAS 37270-89-6) industry. ... Heparin sodium (CAS 9041-08-1) & calcium (CAS 37270-89-6) ... report then explores global and China,s top manufacturers ... 37270-89-6) listing their product specification, capacity, production value, ...
(Date:7/30/2014)... , July 30, 2014   Medical Equipment ... have been awarded a Department of Defense (US Army) ... to supply a mobile MRI diagnostic machine and technical ... Business (WOSB) through the Small Business Administration (SBA), Medical ... the field with the latest medical diagnostic equipment. The ...
Breaking Medicine Technology:Access Pharmaceuticals Featured On OncLive.com 2Access Pharmaceuticals Featured On OncLive.com 3Heparin Sodium & Calcium Industry for Global and Chinese Markets Forecast to 2019 2Heparin Sodium & Calcium Industry for Global and Chinese Markets Forecast to 2019 3Heparin Sodium & Calcium Industry for Global and Chinese Markets Forecast to 2019 4Heparin Sodium & Calcium Industry for Global and Chinese Markets Forecast to 2019 5Medical Equipment Solutions Corp. Awarded $2 Million contract To Service DoD 2
... a leading provider of next generation sequencing assays ... brand name immunoSEQ, announced today it has changed ... (Logo:  http://photos.prnewswire.com/prnh/20120103/SF28632LOGO ) ... the company,s original immune profiling business as well ...
... Inc., a privately-held, commercial-stage, healthcare company focused on the ... nervous system disorders, announced today that Holger Kunze has ... and as a member of the company,s Board of ... appointed as a member of Accera,s BoD. ...
Cached Medicine Technology:Adaptive TCR Changes Name to Adaptive Biotechnologies 2Adaptive TCR Changes Name to Adaptive Biotechnologies 3Accera, Inc. Elects Industry Veteran Holger Kunze as CEO and as a Member of the Company's Board of Directors 2Accera, Inc. Elects Industry Veteran Holger Kunze as CEO and as a Member of the Company's Board of Directors 3
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: